HER2-positive Carcinoma Temporarily Not Available Phase Trials for Margetuximab (DB14967)

IndicationStatusPhase
DBCOND0088269 (HER2-positive Carcinoma)Temporarily Not AvailableNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03133988Margetuximab Expanded Access Program